129 related articles for article (PubMed ID: 8975106)
1. [Physostigmine. From the God's judgment bean to modern antidote and therapeutic agent].
Walter K; Aschoff JC
Med Monatsschr Pharm; 1996 Sep; 19(9):252-60. PubMed ID: 8975106
[No Abstract] [Full Text] [Related]
2. Gamma-hydroxybutyrate overdose and physostigmine: teaching new tricks to an old drug?
Caldicott DG; Kuhn M
Ann Emerg Med; 2001 Jan; 37(1):99-102. PubMed ID: 11145779
[TBL] [Abstract][Full Text] [Related]
3. [Jimson Weed poisoning: an antidote is available in France].
Lagarce L; Monteiro-Rodrigues A; Harry P
Presse Med; 2008 Mar; 37(3 Pt 1):435-7. PubMed ID: 18280100
[No Abstract] [Full Text] [Related]
4. Physostigmine: is there a role for this antidote in pediatric poisonings?
Frascogna N
Curr Opin Pediatr; 2007 Apr; 19(2):201-5. PubMed ID: 17496766
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system depression after ingestion of RenewTrient.
Nelson LS; Howland MA; Hoffman RS
N Engl J Med; 1999 Feb; 340(7):570. PubMed ID: 10026059
[No Abstract] [Full Text] [Related]
6. Central anticholinergics to treat nerve-agent poisoning.
Janowsky DS
Lancet; 2002 Jan; 359(9302):265-6. PubMed ID: 11812600
[No Abstract] [Full Text] [Related]
7. [Doctor, I need an antidote for your antidote. A case biperidene induced anticholinergic syndrome].
Carabaño Aguado I; Pelayo Baeza F; González-Valcárcel Sánchez-Puelles J
An Pediatr (Barc); 2010 May; 72(5):368-9. PubMed ID: 20378434
[No Abstract] [Full Text] [Related]
8. [Development of physostigmine from a poisonous plant to an antidote. One of the most important drugs in the development of modern medicine?].
Rygnestad T
Tidsskr Nor Laegeforen; 1992 Apr; 112(10):1300-3. PubMed ID: 1579914
[TBL] [Abstract][Full Text] [Related]
9. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
10. Physostigmine salicylate as an antidote.
Daunderer M
Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):523-35. PubMed ID: 7228447
[TBL] [Abstract][Full Text] [Related]
11. Physostigmine versus diazepines for anticholinergic poisoning.
Oakley P
Ann Emerg Med; 2001 Feb; 37(2):239-41. PubMed ID: 11174251
[No Abstract] [Full Text] [Related]
12. The early toxicology of physostigmine: a tale of beans, great men and egos.
Proudfoot A
Toxicol Rev; 2006; 25(2):99-138. PubMed ID: 16958557
[TBL] [Abstract][Full Text] [Related]
13. Use of physostigmine for hallucinogenic plant poisoning in a teenager: case report and review of the literature.
Glatstein MM; Alabdulrazzaq F; Garcia-Bournissen F; Scolnik D
Am J Ther; 2012 Sep; 19(5):384-8. PubMed ID: 20861718
[TBL] [Abstract][Full Text] [Related]
14. [Physostigmine: an antidote in diazepam poisoning].
Pedersen JE
Ugeskr Laeger; 1985 Nov; 147(45):3586-7. PubMed ID: 4071801
[No Abstract] [Full Text] [Related]
15. Clinical outcomes in children with hyoscyamus niger intoxication not receiving physostigmine therapy.
Doneray H; Orbak Z; Karakelleoglu C
Eur J Emerg Med; 2007 Dec; 14(6):348-50. PubMed ID: 17968201
[TBL] [Abstract][Full Text] [Related]
16. Physostigmine. Antidote for anticholinergic poisoning.
Snyder BD
Minn Med; 1975 Jun; 58(6):456-7. PubMed ID: 1143251
[No Abstract] [Full Text] [Related]
17. Physostigmine as an antidote for poisoning by combination of thioridazine and trihexyphenidyl.
Beilin B; Vatashsky E; Weinstock M
Br J Clin Pract; 1985 Oct; 39(10):400-1. PubMed ID: 4074628
[No Abstract] [Full Text] [Related]
18. Safety and effectiveness of physostigmine: a 10-year retrospective review.
Arens AM; Shah K; Al-Abri S; Olson KR; Kearney T
Clin Toxicol (Phila); 2018 Feb; 56(2):101-107. PubMed ID: 28703024
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy--physostigmine administered post-operatively].
Haase U; Rundshagen I
Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Mar; 42(3):188-9. PubMed ID: 17366438
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and drug interactions of cholinesterase inhibitors administered in Alzheimer's disease.
Crismon ML
Pharmacotherapy; 1998; 18(2 Pt 2):47-54; discussion 79-82. PubMed ID: 9543465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
